Ready, set, innovate: GSK launches contest for academics
This article was originally published in Scrip
GlaxoSmithKline is kicking off a contest for academic researchers in the US and Canada to test the likelihood of success for early-stage discoveries before the company enters into tough negotiations for collaboration agreements with the institutions where the scientists work.
You may also be interested in...
New report shows average out-of-pocket cost per prescription of $10.67 in 2019 was unchanged from 2018. But while the number of dispensed drugs barely increased, sales jumped more than 5%.
Private Company Edition: Several drug developers targeting neurological diseases raised venture capital recently. In addition to Nura Bio, Encoded Therapeutics revealed a $135m series D round. Also, Longwood closed a $170m fund and Flagship launched Omega Therapeutics with $85m.
The expectation of a big second quarter sales decline proved true, but the situation is improving. Meanwhile, Merck & Co. is advancing two vaccines and an antiviral against the novel coronavirus.